Huieon Lee

South Korea

Poster(s):

• (309) Comparison of Post-Marketing Drug Safety Surveillance Research Required by Regulators of the United States and Europe Through the Case of Dapagliflozin
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (236) Signal Detection for Adverse Events of Dapagliflozin Using the Korea Adverse Event Reporting System Database
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST